Leadership

Officers

Dr. John Keller (President)
President & CEO
Shionogi Inc.

Dr. William Mann (Vice President)
President & CEO
Helsinn Therapeutics (U.S.) Inc.

Ms. Brianne Weingarten (Secretary)
Head of Alliance Management
Licensing & Business Development
Purdue Pharma

Mr. Shoji Yasuda (Treasurer)
President
Taisho Pharmaceutical R&D Inc.

Additional Members of
The Board of Directors

Mr. Yosuke Akita
Vice President, Corporate Planning
Eisai Inc.

Mr. Eric Benn
President & CEO
Taiho Oncology, Inc

Ms. Theresa Covert
AVP Business Development/Developed Markets
Global Human Health
Merck & Co., Inc.

Mr. Mark Dennish
Vice President, Business Development, New Product Planning & Oncology
Daiichi Sankyo Inc.

Dr. Thomas Heffner 
Executive Director, Global Business Development
Pfizer Inc.

Mr. Sang Le
Senior Director of Alliance Management
Otsuka America Pharmaceuticals

Mr. Takeshi Masuda
President & CEO
Kyowa Kirin USA Holdings, Inc.

Dr. Blaine McKee
Head of Transactions
Shire

Mr. Takashi Nagao
President
Mitsubishi Tanabe Pharma Development America &
Mitsubishi Tanabe Pharma America

Mr. Geoffrey Swire
Vice President of Strategic Development
Radius Health

Mr. Kazumi Taguchi 
President
Kyorin USA Inc.

Mr. Tokuhisa Yamato
President
Kissei America, Inc.

Special Advisor

Mr. Hiroyuki Kawabata
Director, Health and Welfare Dept.
JETRO New York